Gheuens Sarahinsider trades
In SEC Form 4 filings, Gheuens Sarah is listed as Chief Medical Officer of Agios Pharmaceuticals, Inc. (AGIO). In the last 90 days, Gheuens Sarah sold $74.6K of Agios Pharmaceuticals, Inc. (AGIO) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| AGIOAgios Pharmaceuticals, Inc. | Chief Medical Officer | 6 | Oct 23 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-10-23
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| AGIOAgios Pharmaceuticals, Inc. | Oct 22 | Oct 23 | M | 500 | $25.01 | $12,505 | 55,145 | Yes | Form 4 |
| AGIOAgios Pharmaceuticals, Inc. | Oct 22 | Oct 23 | S | 500 | $37.52 | Sale −$18,760 | 54,645 | Yes | Form 4 |
| AGIOAgios Pharmaceuticals, Inc. | Oct 22 | Oct 23 | M · derivative | 500 | $25.01 | $12,505 | 24,141 | Yes | Form 4 |
| AGIOAgios Pharmaceuticals, Inc. | Oct 21 | Oct 23 | M | 1,489 | $25.01 | $37,240 | 56,134 | Yes | Form 4 |
| AGIOAgios Pharmaceuticals, Inc. | Oct 21 | Oct 23 | S | 1,489 | $37.53 | Sale −$55,882 | 54,645 | Yes | Form 4 |
| AGIOAgios Pharmaceuticals, Inc. | Oct 21 | Oct 23 | M · derivative | 1,489 | $25.01 | $37,240 | 24,641 | Yes | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.